Globe Pharmaations Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 16-11-2024
- Paid Up Capital ₹ 0.10 M
as on 16-11-2024
- Company Age 11 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 16.50 Cr
as on 16-11-2024
- Revenue 33.23%
(FY 2023)
- Profit -6.88%
(FY 2023)
- Ebitda -18.44%
(FY 2023)
- Net Worth 19.13%
(FY 2023)
- Total Assets 10.46%
(FY 2023)
About Globe Pharmaations
The Company is engaged in the Media And Publishing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹16.50 Cr.
Lalit Srivastava and Prameena Srivastava serve as directors at the Company.
- CIN/LLPIN
U22100MH2013PTC240732
- Company No.
240732
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Feb 2013
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Globe Pharmaations?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Lalit Srivastava  | Director | 26-Feb-2013 | Current |
| Prameena Srivastava | Director | 26-Feb-2013 | Current |
Financial Performance of Globe Pharmaations.
Globe Pharma Publications Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 33.23% increase. The company also saw a slight decrease in profitability, with a 6.88% decrease in profit. The company's net worth Soared by an impressive increase of 19.13%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Globe Pharmaations?
In 2023, Globe Pharmaations had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Maharani Bhog Restaurants LlpActive 4 years 10 monthsLalit Srivastava and Prameena Srivastava are mutual person
- Global Care Pharmacy LlpActive 4 years 3 months
Lalit Srivastava and Prameena Srivastava are mutual person
- Prachi International Restaurants LlpActive 2 years 11 months
Lalit Srivastava and Prameena Srivastava are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 21 Sep 2024 | ₹4.00 Cr | Open |
Others Creation Date: 13 Aug 2024 | ₹1.45 Cr | Open |
Others Creation Date: 19 May 2021 | ₹3.60 Cr | Open |
How Many Employees Work at Globe Pharmaations?
Unlock and access historical data on people associated with Globe Pharmaations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Globe Pharmaations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Globe Pharmaations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
